LivaNova PLC
Last updated September 27, 2026
Organization details
- Legal name
- LivaNova PLC
- Former names
- Sand Holdco Plc
- Ownership
- Public
- Status
- Active
- SIC code
- 3845 — Electromedical & Electrotherapeutic Apparatus
- Jurisdiction of incorporation
- United Kingdom
- Headquarters city
- Gloucester
- Headquarters country
- United Kingdom
- Fiscal year end
- December
- Ticker symbol
- LIVN
- Primary stock exchange
- Nasdaq
Identifiers
- SEC CIK
- 0001639691
- EIN
- 98-1268150
Board of directors
-
Andrea Lynn Saia · DirectorSince 2023
-
Brooke Story · DirectorSince 2023
-
Damien McDonald · Director · CEOSince 2023
-
Daniel Jeffrey Moore · DirectorSince 2023
-
Donald Zurbay · DirectorSince 2025
-
Francesco Bianchi · DirectorSince 2023
-
James Christopher Barry · DirectorSince 2023
-
Jette Nygaard-Andersen · DirectorSince 2026
-
Peter M. Wilver · DirectorSince 2023
-
Seng Stacy Enxing · DirectorSince 2023
-
Sharon O'Kane · DirectorSince 2023
-
Susan M. Podlogar · DirectorSince 2024
-
Todd C. Schermerhorn · DirectorSince 2023
-
Vladimir Makatsaria · Director · Chief Executive OfficerSince 2024
-
William A. Kozy · Director · Chairman and CEOSince 2023
Chief executives
Vladimir Makatsaria
· Chief Executive Officer
Since March 2024
William A. Kozy
· Chairman and CEO
Until March 2024
· Former
Damien McDonald
· CEO
Until March 2024
· Former
Board connections
8 of this board's directors also sit on 11 other boards.
- via Andrea Lynn Saia
- via Peter M. Wilver
- via Donald Zurbay
- via Damien McDonald
- via Andrea Lynn Saia
- via Brooke Story
- via Peter M. Wilver
- via Donald Zurbay
- via Susan M. Podlogar
- via William A. Kozy
- via Todd C. Schermerhorn
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
- Bought, last 12 months
- $0
- 0 purchases by 0 insiders
- Sold, last 12 months
- $1,045,846
- 7 sales by 3 insiders
| Date | Insider | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Sep 10, 2026 | Francesco Bianchi Director | Open-market sale | −3,500 | $78.01 | $273,032 |
| Sep 4, 2026 | Brooke Story Director | Open-market sale | −2,300 | $81.42 | $187,270 |
| Aug 31, 2026 | Francesco Bianchi Director | Open-market sale | −1,650 | $79.72 | $131,538 |
| Aug 11, 2026 | Tezel Ahmet Officer (Chief Innovation Officer) | Option exercise | +12,692 | $52.68 | $668,615 |
| Aug 11, 2026 | Tezel Ahmet Officer (Chief Innovation Officer) | Sold back to the company | −8,589 | $77.86 | $668,740 |
| Aug 11, 2026 | Tezel Ahmet Officer (Chief Innovation Officer) | Shares withheld for tax | −1,428 | $77.86 | $111,184 |
| Aug 11, 2026 | Tezel Ahmet Officer (Chief Innovation Officer) | Open-market sale | −2,675 | $77.74 | $207,942 |
| Jun 15, 2026 | Peter M. Wilver Director | Option exercise | +4,042 | — | — |
| Jun 15, 2026 | Todd C. Schermerhorn Director | Option exercise | +4,042 | — | — |
| Jun 15, 2026 | Francesco Bianchi Director | Option exercise | +4,042 | — | — |
| Jun 15, 2026 | Susan M. Podlogar Director | Option exercise | +4,042 | — | — |
| Jun 15, 2026 | James Christopher Barry Director | Option exercise | +4,042 | — | — |
| Jun 15, 2026 | Tezel Ahmet Officer (Chief Innovation Officer) | Option exercise | +2,965 | — | — |
| Jun 15, 2026 | William A. Kozy Director | Option exercise | +5,681 | — | — |
| Jun 15, 2026 | Seng Stacy Enxing Director | Option exercise | +4,042 | — | — |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.